User profiles for Zhen Liu
Zhen LiuUniversity of Minnesota Verified email at umn.edu Cited by 13887 |
Simplified models for LHC new physics searches
This document proposes a collection of simplified models relevant to the design of new-physics
searches at the Large Hadron Collider (LHC) and the characterization of their results. …
searches at the Large Hadron Collider (LHC) and the characterization of their results. …
Enzyme immobilization on electrospun polymer nanofibers: An overview
Enzyme immobilization has attracted continuous attention in the fields of fine chemistry,
biomedicine, and biosensor. The performance of immobilized enzyme largely depends on the …
biomedicine, and biosensor. The performance of immobilized enzyme largely depends on the …
Production of dimethylfuran for liquid fuels from biomass-derived carbohydrates
Y Román-Leshkov, CJ Barrett, ZY Liu, JA Dumesic - Nature, 2007 - nature.com
Diminishing fossil fuel reserves and growing concerns about global warming indicate that
sustainable sources of energy are needed in the near future. For fuels to be useful in the …
sustainable sources of energy are needed in the near future. For fuels to be useful in the …
[HTML][HTML] Sesamin is one of the major precursors of mammalian lignans in sesame seed (Sesamum indicum) as observed in vitro and in rats
Z Liu, NM Saarinen, LU Thompson - The Journal of nutrition, 2006 - Elsevier
Plant lignans occur in many foods, with flaxseed presently recognized as the richest source.
Some plant lignans can be converted by intestinal microbiota to the mammalian lignans, …
Some plant lignans can be converted by intestinal microbiota to the mammalian lignans, …
[PDF][PDF] A facile one‐step method to produce graphene–CdS quantum dot nanocomposites as promising optoelectronic materials
A Cao, Z Liu, S Chu, M Wu, Z Ye, Z Cai… - Advanced …, 2010 - shimadzu.com.cn
The assembly of semiconductor nanoparticles, such as quantum dots (QDs), on matrices has
been extensively studied for their promising optoelectronic applications.[1–7] To enhance …
been extensively studied for their promising optoelectronic applications.[1–7] To enhance …
On the capacity of hybrid wireless networks
This paper involves the study of the throughput capacity of hybrid wireless networks. A
hybrid network is formed by placing a sparse network of base stations in an ad hoc network. …
hybrid network is formed by placing a sparse network of base stations in an ad hoc network. …
PD‐1 and PD‐L1 upregulation promotes CD8+ T‐cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients
Programmed death 1 (PD‐1) and its ligand (PD‐L1) play pivotal roles in regulating host
immune responses. However, the inhibitory effects of this pathway on the function of cytotoxic …
immune responses. However, the inhibitory effects of this pathway on the function of cytotoxic …
Near-infrared light-triggered, targeted drug delivery to cancer cells by aptamer gated nanovehicles.
X Yang, X Liu, Z Liu, F Pu, J Ren… - … Materials (Deerfield Beach …, 2012 - europepmc.org
A novel cell-targeting, near-infrared light-responsive drug delivery platform based on
mesoporous silica-coated gold nanorods that are surface-functionalized with aptamer DNA is …
mesoporous silica-coated gold nanorods that are surface-functionalized with aptamer DNA is …
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
Tumor molecular profiling is a fundamental component of precision oncology, enabling the
identification of genomic alterations in genes and pathways that can be targeted …
identification of genomic alterations in genes and pathways that can be targeted …
Autism-like behaviours and germline transmission in transgenic monkeys overexpressing MeCP2
Z Liu, X Li, JT Zhang, YJ Cai, TL Cheng, C Cheng… - Nature, 2016 - nature.com
Methyl-CpG binding protein 2 (MeCP2) has crucial roles in transcriptional regulation and
microRNA processing 1 , 2 , 3 , 4 . Mutations in the MECP2 gene are found in 90% of patients …
microRNA processing 1 , 2 , 3 , 4 . Mutations in the MECP2 gene are found in 90% of patients …